FTO‐mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR‐1343‐3p

MLA

Wei Lin, et al. “FTO‐mediated Epigenetic Upregulation of LINC01559 Confers Cell Resistance to Docetaxel in Breast Carcinoma by Suppressing MiR‐1343‐3p.” Kaohsiung Journal of Medical Sciences, vol. 39, no. 9, Sept. 2023, pp. 873–82. EBSCOhost, https://doi.org/10.1002/kjm2.12728.

APA

Wei Lin, Cai‐Qin Mo, Ling‐Jun Kong, Ling Chen, Kun‐Lin Wu, & Xian Wu. (2023). FTO‐mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR‐1343‐3p. Kaohsiung Journal of Medical Sciences, 39(9), 873–882. https://doi.org/10.1002/kjm2.12728

Chicago

Wei Lin, Cai‐Qin Mo, Ling‐Jun Kong, Ling Chen, Kun‐Lin Wu, and Xian Wu. 2023. “FTO‐mediated Epigenetic Upregulation of LINC01559 Confers Cell Resistance to Docetaxel in Breast Carcinoma by Suppressing MiR‐1343‐3p.” Kaohsiung Journal of Medical Sciences 39 (9): 873–82. doi:10.1002/kjm2.12728.